Fig. 1

In vitro inhibition of HOAC viability by carboplatin or kinase inhibitors in monotherapy. HOACs were treated with a dose range of carboplatin, Crizotinib, Dasatinib or Gefitinib in monotherapy and showed cell-specific sensitivity or resistance. a 72 h after treatment, cell viability was determined by a colorimetric assay using SRB (Mean +/− SEM, n ≥ 3). b The IC50 of carboplatin or kinase inhibitors after 72 h of treatment were determined for each cell line (Mean +/− SEM, n ≥ 3)